These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 19944604
1. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog. Zucconi E, Valadares MC, Vieira NM, Bueno CR, Secco M, Jazedje T, da Silva HC, Vainzof M, Zatz M. Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604 [Abstract] [Full Text] [Related]
2. A normal life without muscle dystrophin. Zatz M, Vieira NM, Zucconi E, Pelatti M, Gomes J, Vainzof M, Martins-Bach AB, Garcia Otaduy MC, Bento dos Santos G, Amaro E, Landini V, Andrade T. Neuromuscul Disord; 2015 May; 25(5):371-4. PubMed ID: 25770920 [Abstract] [Full Text] [Related]
3. Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength. Ambrósio CE, Valadares MC, Zucconi E, Cabral R, Pearson PL, Gaiad TP, Canovas M, Vainzof M, Miglino MA, Zatz M. Neuromuscul Disord; 2008 Nov; 18(11):892-3. PubMed ID: 18667316 [No Abstract] [Full Text] [Related]
4. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, Croci D, Davies KE, Cornelio F, Pozza O, Karpati G, Gilbert R, Mora M. Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413 [Abstract] [Full Text] [Related]
8. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Banks GB, Chamberlain JS. Curr Top Dev Biol; 2008 May; 84():431-53. PubMed ID: 19186250 [Abstract] [Full Text] [Related]
9. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. Vieira NM, Spinazzola JM, Alexander MS, Moreira YB, Kawahara G, Gibbs DE, Mead LC, Verjovski-Almeida S, Zatz M, Kunkel LM. Proc Natl Acad Sci U S A; 2017 Jun 06; 114(23):6080-6085. PubMed ID: 28533404 [Abstract] [Full Text] [Related]
10. A canine minidystrophin is functional and therapeutic in mdx mice. Wang B, Li J, Qiao C, Chen C, Hu P, Zhu X, Zhou L, Bogan J, Kornegay J, Xiao X. Gene Ther; 2008 Aug 06; 15(15):1099-106. PubMed ID: 18432277 [Abstract] [Full Text] [Related]
11. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Vieira NM, Valadares M, Zucconi E, Secco M, Bueno CR, Brandalise V, Assoni A, Gomes J, Landini V, Andrade T, Caetano HV, Vainzof M, Zatz M. Cell Transplant; 2012 Aug 06; 21(7):1407-17. PubMed ID: 23168016 [Abstract] [Full Text] [Related]
12. Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. Bartlett RJ, Winand NJ, Secore SL, Singer JT, Fletcher S, Wilton S, Bogan DJ, Metcalf-Bogan JR, Bartlett WT, Howell JM, Cooper BJ, Kornegay JN. Am J Vet Res; 1996 May 06; 57(5):650-4. PubMed ID: 8723876 [Abstract] [Full Text] [Related]
13. Muscular dystrophy-related quantitative and chemical changes in adenohypophysis GH-cells in golden retrievers. de Lima AR, Nyengaard JR, Jorge AA, Balieiro JC, Peixoto C, Fioretto ET, Ambrósio CE, Miglino MA, Zatz M, Ribeiro AA. Growth Horm IGF Res; 2007 Dec 06; 17(6):480-91. PubMed ID: 17664078 [Abstract] [Full Text] [Related]